Researchers at UCLA have developed a powerful new weapon in the battle against kidney cancer. Instead of relying on ...

Researchers explore the impact of CD163-positive tumor-associated macrophages on the effectiveness of nivolumab in treating ...

Earlier this year, a Mayo Clinic retiree created KidneyCouch, an online resource for those with kidney cancer or chronic ...

Neoadjuvant systemic therapy was acceptable to 70% of patients, with 69% of those willing to undergo renal mass biopsy first. While 52% would consider neoadjuvant systemic therapy for ≥16 weeks and 56 ...

UCLA researchers have developed a new kind of immunotherapy that uses specially engineered immune cells equipped with built-in weapons to attack kidney cancer tumors and reprogram their protective ...

UCLA researchers have developed a new kind of immunotherapy that uses specially engineered immune cells equipped with ...

Dr. Alan Tan spoke with CURE® about what patients with kidney cancer and providers who treat it may be able to learn from ctDNA. Among patients with metastatic renal cell carcinoma (mRCC), serial ...

Feb. 19, 2004 — Adjuvant treatment with autologous renal tumor cell vaccine seems to be beneficial in patients with organ-confined renal cell carcinoma, according to the results of a phase III, ...

Triple Olympic champion Jessica Fox revealed on Thursday, Aug. 28, that she has undergone surgery to remove a tumor from her ...

There were 27 patients with 30 affected renal units identified, of which 13 renal units (43%) were treated with kidney-sparing surgery and UGN-101, and 17 renal units (57%) were treated with ...